1. Home
  2. ME vs FLC Comparison

ME vs FLC Comparison

Compare ME & FLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ME
  • FLC
  • Stock Information
  • Founded
  • ME 2006
  • FLC 2003
  • Country
  • ME United States
  • FLC United States
  • Employees
  • ME N/A
  • FLC N/A
  • Industry
  • ME Precision Instruments
  • FLC Trusts Except Educational Religious and Charitable
  • Sector
  • ME Health Care
  • FLC Finance
  • Exchange
  • ME Nasdaq
  • FLC Nasdaq
  • Market Cap
  • ME 168.9M
  • FLC 168.0M
  • IPO Year
  • ME N/A
  • FLC N/A
  • Fundamental
  • Price
  • ME $0.30
  • FLC $16.86
  • Analyst Decision
  • ME Hold
  • FLC
  • Analyst Count
  • ME 1
  • FLC 0
  • Target Price
  • ME $0.47
  • FLC N/A
  • AVG Volume (30 Days)
  • ME 2.5M
  • FLC 37.8K
  • Earning Date
  • ME 11-06-2024
  • FLC 01-01-0001
  • Dividend Yield
  • ME N/A
  • FLC 6.64%
  • EPS Growth
  • ME N/A
  • FLC N/A
  • EPS
  • ME N/A
  • FLC N/A
  • Revenue
  • ME $199,188,000.00
  • FLC N/A
  • Revenue This Year
  • ME $0.05
  • FLC N/A
  • Revenue Next Year
  • ME $17.98
  • FLC N/A
  • P/E Ratio
  • ME N/A
  • FLC N/A
  • Revenue Growth
  • ME N/A
  • FLC N/A
  • 52 Week Low
  • ME $0.30
  • FLC $12.62
  • 52 Week High
  • ME $1.14
  • FLC $15.45
  • Technical
  • Relative Strength Index (RSI)
  • ME 34.05
  • FLC 72.69
  • Support Level
  • ME $0.30
  • FLC $16.75
  • Resistance Level
  • ME $0.32
  • FLC $16.96
  • Average True Range (ATR)
  • ME 0.02
  • FLC 0.14
  • MACD
  • ME 0.00
  • FLC 0.01
  • Stochastic Oscillator
  • ME 8.76
  • FLC 82.76

About ME 23andMe Holding Co.

23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.

About FLC Flaherty & Crumrine Total Return Fund Inc

Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.

Share on Social Networks: